The risk of gastric cancer after vagotomy for benign gastric and duodenal disease was examined in a population based cohort of 7198 patients operated on during 1971-79 and followed up until 1988. After exclusion of the first year of follow up there were 34 cases of gastric cancer compared with 25*6 expected (standardised incidence ratio (SIR) = 1-33; 950/o confidence intervals (CI) 0-92 to 1.86).
Separate analyses by duration of follow up, sex, age at operation, underlying diagnosis, and operative procedures did not show any significant increased or decreased risk of gastric cancer in any of the subgroups. In conclusion, decreased gastric acid secretion after vagotomy does not increase the risk of gastric cancer in the first 10 years after operation or in the subgroup followed up for 10-18 years. A longer follow-up is needed before an excess risk can be excluded. (Gut 1994; 35: 946-949) vagotomy. 20 21 Furthermore, pernicious anaemia, a condition characterised by gastric atrophy, achlorhydria, and hypergastrinaemia, is associated with a considerably increased risk of gastric cancer.22
Any increase in cancer risk after vagotomy may therefore have implications for the longterm treatment with potent drugs for inhibition of gastric acid secretion. Evaluation of any gastric cancer risk after the use of these drugs is limited by the number of longterm users with sufficient treatment duration.23 In contrast, large number of patients who have been subjected to vagotomy are now available with up to almost 20 years of observation. In these patients, as in medically treated patients, the gastric acid secretion is reduced, albeit not abolished, and the secretion of gastrin, a hormone with trophic effects on the stomach mucosa, is slightly increased. 24 Standardised incidence ratios (SIR), the ratio of the observed to expected number of cancers, and 95% confidence intervals (CI) were calculated on the assumption that the observed number of cancers followed a Poisson distribution.28
Results After excluding the first year after operation a total of 34 gastric cancers were diagnosed during the follow up compared with 25-6 expected (SIR=1.33; 95% CI 0-92 to 1-86) ( Table I ). All cancers were histopathologically confirmed. Neither surgical procedures or the various diagnoses at operation were associated with any appreciable differences in relative risk. Although women and patients under the age of 60 had a slightly increased risk of gastric cancer, they did not significantly differ from that of the background population (Table I) . When examined by duration of follow up, risks tended to be lower in the second half of follow up compared with the first nine years (Table II) .
Discussion
The absence of a statistically significant risk increase in this large population based cohort with more than 70 000 person years of observation may seem reassuring. Especially as our results are in contrast with published works so far: in five studies ranging from 209 to 1643 patients, up to a 3-3-fold death risk from gastric cancer was seen.3 21 29-31 The frequent addition of drainage procedures to the vagotomies, and the possibility of surveillance bias in these studies make comparisons with this study difficult. Unoperated duodenal ulcer disease is, however, generally considered to protect against gastric cancer.32 Therefore, a risk close to that seen in the general population may, in fact, reflect an increased risk among duodenal ulcer patients. The role of Helicobacter pylori requires some consideration. It is generally accepted that this infection is closely associated with peptic ulcer.33 There is also accumulating evidence that the infection is positively and independently associated with risk of gastric cancer.3439 As vagotomy seems to have no impact on the infection,40 the Helicobacter associated risk of gastric cancer probably persists even after operation. Whether or not the Helicobacterpylori state is a determinant for the likelihood of being operated -and thus a potential confounder -is largely unknown. It is, however, highly unlikely that an important association between vagotomy and gastric cancer has been concealed in this study through negative confounding by Helicobacter pylori state -that is, that the prevalence of the infection would have been lower among surgical cases than in the general population. In this study the standardised incidence ratios were consistently above unity, one to nine years after operation and for women there was even a significantly increased risk. Although we discarded cancer cases that occurred within one year of the operation, misdiagnosed cancers at time of operation may still have an impact on the rates during the first nine years after operation. Moreover, as the latency period for gastric cancer may be several decades4' 42 a reliable risk estimate after 10-30 years is needed to establish or reject a causative association. As Table I shows, the number of patients with sufficient observation time is clearly too small for firm conclusions.
Misclassification of the exposure (vagotomy) may also entail underestimation of the relative risk. The validity of data in the inpatient registry has been evaluated in a random sample of admissions.43 Codes for surgical procedures were missing in 7-8% (almost half of which were for minor semi-invasive or auxiliary procedures combined with correctly recorded main procedures), and erroneous in 1 8%. Although there is a possibility that, for example, some drainage procedures were not recorded, or that some vagotomies were performed on previously operated stomachs without a diagnosis of gastrojejunal ulcer, the degree of misclassification is of such a low magnitude that it probably has not seriously affected the risk estimates. The cancer cases in this cohort were ascertained through record linkage with the Swedish Cancer Registry. In conclusion, although our results in this study are reassuring, longer follow up is needed before an increased risk for gastric cancer after vagotomy and presumably after longterm medical treatment with H2 blockers can with confidence be ruled out.
